Clinical Trial Update: Safety and Target Engagement of Centella Asiatica in Cognitive Impairment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and target engagement of Centella asiatica extract in individuals with mild cognitive impairment or Alzheimer's dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Centella asiatica extract (Centella asiatica extract)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Mild Cognitive Impairment, Alzheimer's Disease | Phase 1 | Status: RECRUITING